The Standard in Transdermal Bases
Lipoderm was the first proprietary transdermal vehicle in the compounding industry, and it’s the most-studied one as well. In fact, the patented Lipoderm core technology has also led to the development of an entire line of transdermal bases. Lipoderm is scientifically proven to deliver APIs through the skin,* and is supported by an ever-growing portfolio of peer-reviewed journal publications and FormulaPlus™ BUD-studied formulas. It is the ideal base in deep-penetrating topical formulations for local absorption of APIs as well as transdermal formulas for systemic absorption of APIs.
Benefits
- Proven delivery: Several studies published in peer-reviewed journals showed percutaneous absorption of a variety of APIs in Lipoderm, including four APIs at one time*
- Increased quality, efficiency and convenience: The most commonly requested Lipoderm formulations are backed by FormulaPlus BUD studies—which evaluate the chemical potency of a formula through forced degradation in a stability-indicating assay—increasing quality and efficiency for the compounder, and convenience for the patient
- Physical stability: It doesn’t separate with refrigeration, resulting in cosmetically elegant and stable preparations
- Better patient experience: It’s smooth, creamy and non-sticky, and it absorbs quickly
*See the Studies tab for published, peer-reviewed studies that show percutaneous absorption of active pharmaceutical ingredients in Lipoderm.
The Lipoderm Family of Bases
The patented Lipoderm core technology has led to the development of an entire line of transdermal bases, further expanding your options for compounded transdermal and deep-penetrating topical medications to address patients’ needs.
More on the Lipoderm Family